Organigram Strives For ‘High Potency Cannabinoid’ With $6M Phylos Investment
Organigram invests $6 million in Phylos for cannabis genetics innovation, new cannabinoid products and future U.S. market expansion.
Canadian Marijuana Company Announces $500,000 Private Offering
Canadian cannabis company Shiny Health & Wellness Corp. (TSXV: SNYB) announced a non-brokered private placement Wednesday consisting of gross proceeds of up to $500,000. Upon acceptance by the TSXV, it will close on the first tranche of the offering for gross proceeds of $225,000.
Canadian Cannabis Flower Power: Who Are The Top Players? What Happened In Q2 2023?
Zuanic & Associates' recent report unveils the movers and shakers in the flower segment, shedding light on their market shares, pricing strategies and fortunes. The second quarter of 2023 saw some intriguing shifts in the sector.
Cannabis Chart Of The Week: Are There Good Values Among Canadian Cannabis Companies?
This week's chart explores the valuation and credit of the eighteen U.S. and Canadian cannabis companies with market caps between $20M and $100M. The presence of U.S. and Canadian companies in the group allows for comparing credit quality and valuation.
Canadian Cannabis Company Boasts Record Sales For Q3 2023: 114% Increase Over Last Year
Ayurcann Holdings Corp. (OTCQB: AYURF) a leading Canadian cannabis company specializing in the processing and manufacturing of cannabis 2.0 and 3.0 products in the recreational market announced its financial and operational results for the three- and nine-months ended March 31, 2023.